Function
AKT2 is one of three closely related serine/threonine-protein kinases (AKT1, AKT2, and AKT3) collectively known as the AKT kinase. These kinases play a crucial role in regulating a wide range of cellular processes, including metabolism, proliferation, cell survival, growth, and angiogenesis. This regulation is primarily mediated through serine and/or threonine phosphorylation of various downstream substrates. Over 100 potential substrate candidates have been identified to date, but for the majority of them, isoform specificity remains undefined. AKT is responsible for regulating glucose uptake by facilitating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively regulates its phosphatase activity, preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, a crucial step in insulin-stimulated glucose transport. AKT also regulates glucose storage in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', leading to inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also believed to be a mechanism driving cell proliferation. AKT further regulates cell survival by phosphorylating MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' reduces MAP3K5 kinase activity stimulated by oxidative stress, thus preventing apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling, ultimately leading to both phosphorylation of 4E-BP1 and activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), resulting in binding of 14-3-3 proteins and cytoplasmic localization. Specifically, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256', and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated at equivalent sites. AKT plays a significant role in regulating NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). Phosphorylation of CREB1 induces the binding of accessory proteins necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), potentially regulating ACLY activity and fatty acid synthesis. It activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. AKT phosphorylates PIKFYVE on 'Ser-318', leading to increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate, and its phosphorylation is implicated in regulating cell proliferation and cell growth. AKT acts as a key modulator of the AKT-mTOR signaling pathway, controlling the tempo of newborn neuron integration during adult neurogenesis, including correct neuron positioning, dendritic development, and synapse formation. AKT signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors, including platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin, and insulin-like growth factor I (IGF-I). AKT mediates the antiapoptotic effects of IGF-I. It is essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. AKT may be involved in regulating placental development. One of the few specific substrates of AKT2 recently identified is PITX2. Phosphorylation of PITX2 impairs its association with the CCND1 mRNA-stabilizing complex, thereby shortening the half-life of CCND1. AKT2 appears to be the principal isoform responsible for regulating glucose uptake. AKT2 phosphorylates C2CD5 on 'Ser-197' during insulin-stimulated adipocytes. AKT2 is also specifically involved in skeletal muscle differentiation, one of its substrates in this process being ANKRD2. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase-dependent apoptosis. AKT2 phosphorylates CLK2 on 'Thr-343'.